Published in Medical Letter on the CDC and FDA, September 20th, 2009
"To evaluate the influence of pre- and postoperative disc height on postoperative motion and clinical outcomes. Retrospective review of patients enrolled in prospective randomized Food and Drug Administration (FDA) trial. SAMPLE: One hundred sixty-six patients with single-level ProDisc-C arthroplasty performed were evaluated. ROM and clinical outcomes based on Neck Disability Index (NDI) and Visual Analog...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA